Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice

Proceedings of the Western Pharmacology Society

Volumn 54, Issue , 2011, Pages 5-9

  Ventura Sobrevilla, J ^a   Boone Villa, V D ^b   Aguilar, C N ^b   Roman Ramos R ^a   Vega Avila E ^a   Campos Sepulveda E ^c   Alarcon Aguilar F ^a  

^a DEPARTAMENTO DE QUÍMICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE COAHUILA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; STREPTOZOCIN;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; MORTALITY; MOUSE; NONHUMAN; WEIGHT REDUCTION; ANIMAL; BLOOD; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; STREPTOZOCIN;

EID: 84859704201     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. ADA, American Diabetes Association. (2009) Diabetes Care. 32, S62-S67.
2. WHO, World Health Organization. (2010) [WWW page] URL http://www.who.int. Fact sheet No 312
3. Tesch, G.H. and Allen T.J. (2007) Nephrology. 12, 261-266.
4. McNeill, J.H. (1999) Experimental Model of Diabetes.1st Ed.,CRC Press, Florida.
5. Szkudelski, T. (2001) Physiol Res. 50, 536-546.
6. NOM-062-ZOO-1999. Especificaciones y técnicas para la producción, cuidado y uso de los animales de laboratorio.
7. Bansal, P., Piya, P., Mudgal, J., Pawan, G.N. and Steve, T.P. (2011) Exp. Toxilcol. Pathol. In press.
8. Arias-Díaz, J. and Balibrea, J. (2007) Nutr. Hosp. 22, 160-168.
9. Boroujeni, N.B., Hashemi, S.M., Khaki, Z. and Soleimani, M. (2011) Tissue and Cell. 43, 75-82.
10. Gurley, S.B., Clare, S.E., Snow, K.P.,Hu, A., Meyer, T.W. and Coffman, T.M. (2006) Am. J. Physiol. Renal Physiol. 290, F214-F222.
11. Valentovic, M.A., Alejandro, N., Betts, C.A., Brown, P.I. and Ramos, K. (2006). Toxicol Lett. 164, 214-220.
12. Strandell, E., Eizirik, D.L., Korsgren, O., and Sandler, S. (1998) Mol. Cell Endocrinoll. 59, 83-91.
13. Krentz, A.J. (2003) Diab. Obes. Metab. 5, S19-S21.
14. Konrad, R.J., Mikolaenko, I., Tolar, J.F., Liu, K. and Kudlow, J.E. (2001) Biochem. J. 356, 31-41.
15. Mori, D.B., Baviera, A.M., Ramalho, L.T.D.O., Vendramini, R.C., Brunetti, I.L.and Pepato M.T. (2003) Biotechnol. App. Biochem.38, 183-191.
16. Fleig, P., Marliss, E., Ohman, J. and Cahill, J.F. (1970) Diabetes. 19, 727-729
17. Shirwaikar, A., Rajendar, K. and Kumar, C.D. (2004) J. Ethnopharmacol. 91, 171-175.